A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01688531

Enrollment

Registered

2012-09-20

Start date

2012-08-31

Completion date

2013-09-30

Last updated

2019-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Brief summary

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

Interventions

DRUGCD0271 0.1%/CD1579 2.5% gel

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

DRUGCD0271 0.1%/CD1579 2.5% gel vehicle

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Inclusion criteria

* Male or female subjects aged 18 to 35 years inclusive * Subjects with active, moderate acne

Exclusion criteria

* The subject has a secondary acne form (chloracne, drug-induced acne, etc.) (Screening) * The subject has a severity of acne that is not amenable to treatment with CD0271-CD1579 (Screening)

Design outcomes

Primary

Measure	Time frame
Description and documentation of acne lesions	over 6 months

Secondary

Measure	Time frame
Treatment effect on acne lesions	over 6 months

Countries

Canada, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026